Dr John Adcock

Specialising in and with a recognised expertise in sensory neurophysiology and neuropharmacology, particularly in airway disease (including airway hyperresponsiveness, asthma, COPD and chronic cough). My career spans about 47 years ‘in the business’: 26 years at the Wellcome Research Laboratories, 6 years as Co-founder, Director and Chairman of Pneumolabs (UK) Ltd, 8 years as a team leader at Pfizer and, currently, for the last seven years in academia. After taking early retirement from the Industry and now as an Honorary Senior Lecturer, I am actively and passionately involved in research within the Respiratory Pharmacology Group at Imperial College to support and enhance activities within the group across multiple Projects aimed at elucidating airway sensory nerve mechanisms, in particular cough and the development of antitussives. This also involves teaching and supervising research staff and students in the theoretical and practical realms of in vivo Electrophysiology.